| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Blood Pressure | 57 | 2020 | 2198 | 6.53 | Why? |
| Blood Pressure Determination | 27 | 2020 | 450 | 4.66 | Why? |
| Blood Pressure Monitoring, Ambulatory | 20 | 2019 | 341 | 3.74 | Why? |
| Hypertension | 55 | 2021 | 8895 | 3.40 | Why? |
| Vascular Stiffness | 10 | 2019 | 264 | 3.20 | Why? |
| Antihypertensive Agents | 21 | 2019 | 1962 | 1.91 | Why? |
| Pulse Wave Analysis | 10 | 2019 | 221 | 1.70 | Why? |
| Heart Failure | 20 | 2021 | 6638 | 1.56 | Why? |
| Marfan Syndrome | 2 | 2018 | 27 | 1.42 | Why? |
| Sleep Apnea, Obstructive | 6 | 2018 | 668 | 1.34 | Why? |
| Sleep Apnea Syndromes | 4 | 2021 | 282 | 1.34 | Why? |
| Carotid Arteries | 3 | 2018 | 182 | 1.29 | Why? |
| Hemodynamics | 9 | 2021 | 1562 | 1.29 | Why? |
| Arrhythmogenic Right Ventricular Dysplasia | 4 | 2020 | 56 | 1.26 | Why? |
| Baroreflex | 5 | 2019 | 54 | 1.16 | Why? |
| Sphygmomanometers | 4 | 2019 | 14 | 1.11 | Why? |
| Masked Hypertension | 4 | 2018 | 15 | 1.04 | Why? |
| Autonomic Nervous System | 2 | 2019 | 148 | 1.03 | Why? |
| Dihydropyridines | 2 | 2019 | 29 | 0.95 | Why? |
| Altitude | 3 | 2018 | 311 | 0.93 | Why? |
| Hypertension, Pulmonary | 6 | 2020 | 970 | 0.92 | Why? |
| Exercise Test | 7 | 2021 | 911 | 0.91 | Why? |
| Enalapril | 2 | 2018 | 54 | 0.90 | Why? |
| Pulsatile Flow | 2 | 2019 | 123 | 0.87 | Why? |
| Circadian Rhythm | 5 | 2019 | 607 | 0.84 | Why? |
| American Heart Association | 2 | 2019 | 347 | 0.81 | Why? |
| Heart | 5 | 2018 | 1791 | 0.80 | Why? |
| Heart Atria | 2 | 2019 | 267 | 0.77 | Why? |
| Systole | 3 | 2019 | 252 | 0.77 | Why? |
| Ablation Techniques | 1 | 2019 | 54 | 0.76 | Why? |
| Vasodilation | 2 | 2018 | 258 | 0.75 | Why? |
| Calcium Channel Blockers | 3 | 2018 | 367 | 0.75 | Why? |
| Fibrillin-1 | 1 | 2018 | 6 | 0.74 | Why? |
| Cardiac Catheterization | 5 | 2021 | 882 | 0.74 | Why? |
| Amlodipine | 2 | 2018 | 45 | 0.74 | Why? |
| Atrial Function, Left | 1 | 2019 | 82 | 0.73 | Why? |
| Tetrazoles | 2 | 2018 | 262 | 0.72 | Why? |
| Varicose Veins | 1 | 2018 | 30 | 0.72 | Why? |
| Sodium, Dietary | 1 | 2018 | 45 | 0.71 | Why? |
| Saphenous Vein | 1 | 2018 | 67 | 0.69 | Why? |
| Pulmonary Veins | 1 | 2019 | 146 | 0.69 | Why? |
| Echocardiography | 12 | 2021 | 3661 | 0.68 | Why? |
| Radiation Injuries | 1 | 2019 | 140 | 0.68 | Why? |
| Prostheses and Implants | 1 | 2017 | 116 | 0.64 | Why? |
| Catheter Ablation | 2 | 2018 | 438 | 0.63 | Why? |
| Blood Vessels | 1 | 2018 | 228 | 0.63 | Why? |
| Running | 1 | 2018 | 153 | 0.62 | Why? |
| Altitude Sickness | 3 | 2018 | 95 | 0.61 | Why? |
| Cardiovascular Diseases | 19 | 2020 | 11497 | 0.60 | Why? |
| Coronary Circulation | 1 | 2017 | 188 | 0.60 | Why? |
| Coronary Stenosis | 1 | 2019 | 273 | 0.59 | Why? |
| Arteries | 1 | 2018 | 283 | 0.59 | Why? |
| Heart Rate | 7 | 2019 | 1527 | 0.59 | Why? |
| Renal Insufficiency, Chronic | 3 | 2018 | 2654 | 0.58 | Why? |
| Aorta, Thoracic | 1 | 2017 | 271 | 0.58 | Why? |
| Electric Impedance | 1 | 2017 | 283 | 0.57 | Why? |
| Ventricular Function, Right | 1 | 2018 | 388 | 0.57 | Why? |
| Radiation Dosage | 1 | 2019 | 585 | 0.55 | Why? |
| Vasoconstriction | 3 | 2020 | 153 | 0.52 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 669 | 0.52 | Why? |
| Endothelin-1 | 2 | 2019 | 69 | 0.52 | Why? |
| Mobile Applications | 3 | 2018 | 3032 | 0.51 | Why? |
| Heart Ventricles | 3 | 2018 | 1139 | 0.50 | Why? |
| Aortic Diseases | 1 | 2018 | 362 | 0.50 | Why? |
| Respiratory Rate | 1 | 2017 | 691 | 0.48 | Why? |
| Imidazoles | 1 | 2018 | 631 | 0.48 | Why? |
| Myocardial Ischemia | 2 | 2017 | 781 | 0.47 | Why? |
| Pulmonary Artery | 2 | 2017 | 803 | 0.46 | Why? |
| Aorta | 4 | 2019 | 355 | 0.45 | Why? |
| Societies, Medical | 7 | 2019 | 6907 | 0.45 | Why? |
| Exercise Therapy | 2 | 2017 | 976 | 0.44 | Why? |
| Ischemia | 1 | 2018 | 901 | 0.40 | Why? |
| Blood Pressure Monitors | 2 | 2020 | 28 | 0.40 | Why? |
| Vascular Resistance | 3 | 2020 | 148 | 0.40 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2009 | 70 | 0.39 | Why? |
| Stroke Volume | 6 | 2021 | 2153 | 0.39 | Why? |
| Manometry | 3 | 2018 | 91 | 0.39 | Why? |
| Coronary Angiography | 1 | 2019 | 2275 | 0.38 | Why? |
| Sleep | 4 | 2019 | 2695 | 0.38 | Why? |
| Hypotension | 3 | 2018 | 392 | 0.38 | Why? |
| Humans | 121 | 2021 | 930598 | 0.36 | Why? |
| Pericardium | 2 | 2020 | 228 | 0.36 | Why? |
| Oxygen Consumption | 4 | 2021 | 711 | 0.35 | Why? |
| Hypoxia | 3 | 2020 | 3626 | 0.35 | Why? |
| Endovascular Procedures | 1 | 2018 | 1302 | 0.35 | Why? |
| Atrial Fibrillation | 2 | 2019 | 2320 | 0.34 | Why? |
| Potassium Channels, Voltage-Gated | 1 | 2006 | 13 | 0.34 | Why? |
| Telemedicine | 8 | 2020 | 25032 | 0.33 | Why? |
| Chronic Disease | 3 | 2017 | 5139 | 0.33 | Why? |
| Cardiology | 2 | 2019 | 2873 | 0.32 | Why? |
| Endothelin Receptor Antagonists | 1 | 2006 | 47 | 0.32 | Why? |
| Patient Education as Topic | 1 | 2016 | 1476 | 0.31 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 6 | 2018 | 5277 | 0.30 | Why? |
| Workplace | 1 | 2018 | 2075 | 0.30 | Why? |
| Middle Aged | 54 | 2021 | 270681 | 0.30 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.30 | Why? |
| Prognosis | 17 | 2021 | 32490 | 0.30 | Why? |
| Male | 67 | 2021 | 367725 | 0.29 | Why? |
| Ventricular Function, Left | 4 | 2018 | 1555 | 0.29 | Why? |
| Polysomnography | 5 | 2018 | 296 | 0.29 | Why? |
| Heart Diseases | 3 | 2018 | 3503 | 0.28 | Why? |
| Female | 64 | 2021 | 380317 | 0.28 | Why? |
| White Coat Hypertension | 3 | 2018 | 24 | 0.28 | Why? |
| Microcirculation | 2 | 2018 | 447 | 0.25 | Why? |
| Aged | 40 | 2021 | 215776 | 0.25 | Why? |
| Life Style | 4 | 2021 | 2708 | 0.24 | Why? |
| Follow-Up Studies | 13 | 2021 | 17020 | 0.23 | Why? |
| Practice Guidelines as Topic | 6 | 2019 | 15421 | 0.23 | Why? |
| Validation Studies as Topic | 2 | 2018 | 121 | 0.22 | Why? |
| Arrhythmias, Cardiac | 3 | 2021 | 2510 | 0.22 | Why? |
| Mutation, Missense | 2 | 2017 | 863 | 0.22 | Why? |
| Sleep Apnea, Central | 2 | 2017 | 28 | 0.22 | Why? |
| Breast Neoplasms | 1 | 2019 | 3633 | 0.22 | Why? |
| Consensus | 5 | 2019 | 6345 | 0.22 | Why? |
| Stroke | 4 | 2018 | 8839 | 0.22 | Why? |
| Adrenergic beta-Antagonists | 3 | 2018 | 465 | 0.21 | Why? |
| Atrial Pressure | 1 | 2019 | 5 | 0.21 | Why? |
| Electrocardiography | 6 | 2020 | 3957 | 0.20 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.20 | Why? |
| Atenolol | 1 | 2019 | 7 | 0.20 | Why? |
| Primary Prevention | 2 | 2017 | 778 | 0.20 | Why? |
| Hypercapnia | 1 | 2021 | 172 | 0.20 | Why? |
| Aminophenols | 1 | 2019 | 22 | 0.20 | Why? |
| Ventricular Dysfunction, Left | 2 | 2018 | 993 | 0.20 | Why? |
| Nebivolol | 1 | 2019 | 12 | 0.20 | Why? |
| Diuretics | 2 | 2018 | 326 | 0.20 | Why? |
| Cardiac Volume | 1 | 2018 | 10 | 0.20 | Why? |
| Italy | 14 | 2021 | 38444 | 0.19 | Why? |
| Antibodies, Anticardiolipin | 1 | 2020 | 208 | 0.19 | Why? |
| Reticular Formation | 1 | 2018 | 3 | 0.19 | Why? |
| Proliferating Cell Nuclear Antigen | 1 | 2018 | 18 | 0.19 | Why? |
| Exercise Tolerance | 2 | 2021 | 634 | 0.19 | Why? |
| Benzodioxoles | 1 | 2019 | 78 | 0.19 | Why? |
| Metanephrine | 1 | 2018 | 8 | 0.19 | Why? |
| Heart Failure, Systolic | 1 | 2018 | 39 | 0.19 | Why? |
| Polycythemia | 1 | 2018 | 19 | 0.18 | Why? |
| Cheyne-Stokes Respiration | 1 | 2017 | 5 | 0.18 | Why? |
| Radiotherapy, Adjuvant | 1 | 2019 | 180 | 0.18 | Why? |
| Femoral Artery | 2 | 2017 | 213 | 0.18 | Why? |
| Sodium Chloride Symporter Inhibitors | 1 | 2018 | 45 | 0.18 | Why? |
| Air Pressure | 1 | 2018 | 119 | 0.18 | Why? |
| Aminopyridines | 1 | 2019 | 121 | 0.18 | Why? |
| Calcium Channels | 1 | 2018 | 96 | 0.18 | Why? |
| Kidney | 2 | 2017 | 3648 | 0.18 | Why? |
| Blood Flow Velocity | 1 | 2019 | 193 | 0.18 | Why? |
| Desmoplakins | 1 | 2017 | 6 | 0.18 | Why? |
| Time Factors | 11 | 2021 | 31397 | 0.18 | Why? |
| Neurophysiology | 1 | 2018 | 86 | 0.18 | Why? |
| Breath Holding | 1 | 2017 | 13 | 0.17 | Why? |
| Double-Blind Method | 5 | 2019 | 5988 | 0.17 | Why? |
| Carotid Artery Diseases | 2 | 2019 | 251 | 0.17 | Why? |
| Randomized Controlled Trials as Topic | 9 | 2018 | 10649 | 0.17 | Why? |
| Carotid Artery, Common | 1 | 2017 | 49 | 0.17 | Why? |
| Quinolones | 1 | 2019 | 167 | 0.17 | Why? |
| Sulfonamides | 1 | 2006 | 1294 | 0.17 | Why? |
| Propanolamines | 1 | 2017 | 47 | 0.17 | Why? |
| Hydrochlorothiazide | 1 | 2017 | 31 | 0.17 | Why? |
| Sympathectomy | 1 | 2017 | 67 | 0.17 | Why? |
| Pulmonary Ventilation | 1 | 2019 | 152 | 0.17 | Why? |
| Renin | 1 | 2018 | 167 | 0.17 | Why? |
| Cross-Over Studies | 2 | 2019 | 867 | 0.16 | Why? |
| Mortality | 3 | 2018 | 7132 | 0.16 | Why? |
| Europe | 6 | 2019 | 12702 | 0.16 | Why? |
| Recovery of Function | 2 | 2018 | 2461 | 0.16 | Why? |
| Captopril | 1 | 2017 | 39 | 0.16 | Why? |
| DNA Mutational Analysis | 1 | 2019 | 581 | 0.16 | Why? |
| Blood | 1 | 2018 | 274 | 0.16 | Why? |
| Aldosterone | 1 | 2018 | 155 | 0.16 | Why? |
| Hyperventilation | 1 | 2016 | 59 | 0.16 | Why? |
| Ultrasonography, Doppler, Duplex | 1 | 2018 | 168 | 0.16 | Why? |
| Physicians | 1 | 2016 | 4214 | 0.16 | Why? |
| Cadherins | 1 | 2017 | 145 | 0.16 | Why? |
| Healthy Lifestyle | 2 | 2018 | 447 | 0.16 | Why? |
| Benzoates | 1 | 2017 | 102 | 0.16 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2019 | 219 | 0.16 | Why? |
| Myocardial Contraction | 1 | 2017 | 123 | 0.16 | Why? |
| Dilatation | 1 | 2018 | 181 | 0.16 | Why? |
| Calcium | 2 | 2018 | 708 | 0.16 | Why? |
| Pyridazines | 1 | 2017 | 86 | 0.16 | Why? |
| Treatment Outcome | 14 | 2020 | 51732 | 0.16 | Why? |
| Smartphone | 2 | 2018 | 1840 | 0.16 | Why? |
| Insulin Resistance | 2 | 2019 | 669 | 0.16 | Why? |
| Anti-Arrhythmia Agents | 1 | 2019 | 325 | 0.16 | Why? |
| Iron Overload | 1 | 2018 | 113 | 0.16 | Why? |
| Carbazoles | 1 | 2017 | 120 | 0.15 | Why? |
| Disease Management | 3 | 2020 | 6841 | 0.15 | Why? |
| Absenteeism | 1 | 2018 | 287 | 0.15 | Why? |
| Sodium | 1 | 2018 | 309 | 0.15 | Why? |
| Uric Acid | 1 | 2019 | 285 | 0.15 | Why? |
| Adult | 30 | 2021 | 244371 | 0.15 | Why? |
| Hydrazones | 1 | 2017 | 216 | 0.15 | Why? |
| Case Management | 1 | 2018 | 285 | 0.15 | Why? |
| Exome | 1 | 2017 | 207 | 0.15 | Why? |
| Death, Sudden, Cardiac | 2 | 2019 | 522 | 0.15 | Why? |
| Biphenyl Compounds | 1 | 2017 | 249 | 0.15 | Why? |
| Linear Models | 2 | 2019 | 1914 | 0.15 | Why? |
| Folic Acid | 1 | 2017 | 172 | 0.15 | Why? |
| Self-Management | 2 | 2018 | 546 | 0.15 | Why? |
| Severity of Illness Index | 8 | 2021 | 48226 | 0.14 | Why? |
| Adipose Tissue | 1 | 2020 | 612 | 0.14 | Why? |
| Cardiac Imaging Techniques | 1 | 2018 | 357 | 0.14 | Why? |
| beta-Thalassemia | 1 | 2018 | 200 | 0.14 | Why? |
| Risk Factors | 19 | 2021 | 71621 | 0.14 | Why? |
| Patient Compliance | 3 | 2018 | 1468 | 0.14 | Why? |
| Prospective Studies | 12 | 2021 | 43301 | 0.14 | Why? |
| Pain Measurement | 1 | 2018 | 533 | 0.14 | Why? |
| Sick Leave | 1 | 2018 | 318 | 0.14 | Why? |
| Antiphospholipid Syndrome | 1 | 2020 | 533 | 0.14 | Why? |
| Benzimidazoles | 1 | 2017 | 275 | 0.14 | Why? |
| Risk Reduction Behavior | 2 | 2018 | 946 | 0.14 | Why? |
| Aged, 80 and over | 15 | 2021 | 88759 | 0.13 | Why? |
| Carbon Dioxide | 1 | 2021 | 917 | 0.13 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.13 | Why? |
| Syndrome | 1 | 2019 | 1310 | 0.13 | Why? |
| Diastole | 3 | 2019 | 168 | 0.13 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.13 | Why? |
| Cardiotonic Agents | 1 | 2017 | 418 | 0.13 | Why? |
| Quality Indicators, Health Care | 1 | 2019 | 580 | 0.13 | Why? |
| Phenotype | 3 | 2019 | 4037 | 0.13 | Why? |
| Diet, Mediterranean | 1 | 2017 | 351 | 0.13 | Why? |
| Pediatric Obesity | 1 | 2018 | 492 | 0.12 | Why? |
| Plaque, Atherosclerotic | 1 | 2017 | 423 | 0.12 | Why? |
| Nomograms | 1 | 2019 | 790 | 0.12 | Why? |
| Long QT Syndrome | 2 | 2019 | 1047 | 0.12 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.12 | Why? |
| Magnetic Resonance Imaging | 2 | 2020 | 6551 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| Heart Function Tests | 1 | 2012 | 101 | 0.12 | Why? |
| Nitric Oxide | 1 | 2019 | 769 | 0.11 | Why? |
| Registries | 4 | 2020 | 12327 | 0.11 | Why? |
| Respiration | 1 | 2017 | 729 | 0.11 | Why? |
| Cross-Sectional Studies | 8 | 2019 | 53120 | 0.11 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.11 | Why? |
| Drug Combinations | 2 | 2019 | 3852 | 0.11 | Why? |
| Return to Work | 1 | 2018 | 579 | 0.11 | Why? |
| Kidney Failure, Chronic | 2 | 2017 | 3222 | 0.11 | Why? |
| Noncommunicable Diseases | 1 | 2020 | 934 | 0.11 | Why? |
| Sodium Chloride, Dietary | 1 | 2011 | 62 | 0.11 | Why? |
| Midodrine | 1 | 2009 | 7 | 0.10 | Why? |
| Defibrillators, Implantable | 1 | 2017 | 624 | 0.10 | Why? |
| Adrenergic alpha-Agonists | 1 | 2009 | 45 | 0.10 | Why? |
| Risk Assessment | 6 | 2021 | 25439 | 0.10 | Why? |
| Reproducibility of Results | 8 | 2018 | 11304 | 0.10 | Why? |
| Kidney Function Tests | 1 | 2012 | 520 | 0.10 | Why? |
| Oxygen | 2 | 2018 | 3715 | 0.10 | Why? |
| Drug Therapy, Combination | 3 | 2018 | 7268 | 0.10 | Why? |
| Adolescent | 12 | 2020 | 86841 | 0.10 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.09 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.09 | Why? |
| Continuous Positive Airway Pressure | 1 | 2018 | 1187 | 0.09 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.09 | Why? |
| Bariatric Surgery | 1 | 2018 | 1298 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.09 | Why? |
| Microcomputers | 1 | 2007 | 20 | 0.09 | Why? |
| Receptors, Endothelin | 1 | 2006 | 13 | 0.08 | Why? |
| Arginine Vasopressin | 1 | 2006 | 14 | 0.08 | Why? |
| Diuresis | 1 | 2006 | 14 | 0.08 | Why? |
| Angiotensin Receptor Antagonists | 3 | 2018 | 3892 | 0.08 | Why? |
| Delivery of Health Care, Integrated | 1 | 2019 | 1549 | 0.08 | Why? |
| Osmolar Concentration | 1 | 2006 | 86 | 0.08 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.08 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.08 | Why? |
| Muscle, Smooth, Vascular | 1 | 2006 | 86 | 0.08 | Why? |
| Morbidity | 2 | 2017 | 1426 | 0.08 | Why? |
| Death, Sudden | 2 | 2018 | 160 | 0.08 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.07 | Why? |
| Young Adult | 6 | 2018 | 93724 | 0.07 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.07 | Why? |
| Disease Progression | 3 | 2019 | 13580 | 0.07 | Why? |
| Vasoconstrictor Agents | 1 | 2009 | 714 | 0.07 | Why? |
| Outpatients | 1 | 2018 | 3417 | 0.07 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.07 | Why? |
| Sleep Wake Disorders | 1 | 2017 | 1463 | 0.07 | Why? |
| Genetic Variation | 1 | 2019 | 3919 | 0.07 | Why? |
| Japan | 1 | 2018 | 6653 | 0.07 | Why? |
| Computers, Handheld | 1 | 2007 | 242 | 0.07 | Why? |
| Pilot Projects | 1 | 2016 | 5182 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Cohort Studies | 5 | 2019 | 36005 | 0.07 | Why? |
| Forecasting | 1 | 2019 | 4492 | 0.07 | Why? |
| Obesity | 3 | 2021 | 7388 | 0.07 | Why? |
| Renal Dialysis | 2 | 2019 | 4358 | 0.07 | Why? |
| Syncope, Vasovagal | 1 | 2003 | 16 | 0.07 | Why? |
| Dose-Response Relationship, Drug | 3 | 2018 | 3776 | 0.07 | Why? |
| Reference Standards | 2 | 2018 | 1163 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Adaptation, Physiological | 1 | 2006 | 359 | 0.06 | Why? |
| Practice Patterns, Physicians' | 2 | 2021 | 4927 | 0.06 | Why? |
| Survival Rate | 4 | 2019 | 9206 | 0.06 | Why? |
| Sensitivity and Specificity | 3 | 2019 | 22971 | 0.06 | Why? |
| Pulmonary Edema | 1 | 2006 | 430 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.06 | Why? |
| Child | 7 | 2019 | 70012 | 0.06 | Why? |
| Incidence | 6 | 2021 | 25622 | 0.06 | Why? |
| Inspiratory Capacity | 1 | 2021 | 47 | 0.06 | Why? |
| History, 20th Century | 2 | 2018 | 1282 | 0.06 | Why? |
| Diabetes Mellitus | 3 | 2021 | 8207 | 0.06 | Why? |
| Renin-Angiotensin System | 1 | 2017 | 3661 | 0.06 | Why? |
| United States | 2 | 2019 | 46150 | 0.06 | Why? |
| Lung Volume Measurements | 1 | 2021 | 115 | 0.06 | Why? |
| beta 2-Glycoprotein I | 1 | 2020 | 92 | 0.05 | Why? |
| Hypertrophy, Right Ventricular | 1 | 2020 | 33 | 0.05 | Why? |
| History, 21st Century | 2 | 2018 | 1849 | 0.05 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.05 | Why? |
| Ventilation-Perfusion Ratio | 1 | 2020 | 99 | 0.05 | Why? |
| Phosphatidylserines | 1 | 2020 | 99 | 0.05 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.05 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2017 | 3051 | 0.05 | Why? |
| Calmodulin | 1 | 2019 | 15 | 0.05 | Why? |
| Glomerular Filtration Rate | 1 | 2006 | 1262 | 0.05 | Why? |
| Prothrombin | 1 | 2020 | 149 | 0.05 | Why? |
| Creatinine | 1 | 2006 | 1443 | 0.05 | Why? |
| Exercise | 2 | 2018 | 6771 | 0.05 | Why? |
| Oscillometry | 1 | 2019 | 50 | 0.05 | Why? |
| Cardiac Output | 1 | 2020 | 183 | 0.05 | Why? |
| Cardiac Electrophysiology | 1 | 2021 | 239 | 0.05 | Why? |
| Calcifediol | 1 | 2021 | 191 | 0.05 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.05 | Why? |
| Lung Compliance | 1 | 2020 | 243 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Sexual Maturation | 1 | 2018 | 18 | 0.05 | Why? |
| Non-Randomized Controlled Trials as Topic | 1 | 2019 | 220 | 0.05 | Why? |
| Arm | 1 | 2019 | 159 | 0.05 | Why? |
| Pulmonary Wedge Pressure | 1 | 2018 | 53 | 0.05 | Why? |
| Auscultation | 1 | 2019 | 115 | 0.04 | Why? |
| Biological Oxygen Demand Analysis | 1 | 2017 | 13 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Journalism, Medical | 1 | 2018 | 50 | 0.04 | Why? |
| Proportional Hazards Models | 3 | 2018 | 6543 | 0.04 | Why? |
| Congresses as Topic | 2 | 2017 | 1347 | 0.04 | Why? |
| Stress, Psychological | 1 | 2021 | 10231 | 0.04 | Why? |
| Arterial Pressure | 1 | 2019 | 208 | 0.04 | Why? |
| Age of Onset | 1 | 2019 | 557 | 0.04 | Why? |
| Certification | 1 | 2020 | 261 | 0.04 | Why? |
| Brain Stem | 1 | 2018 | 131 | 0.04 | Why? |
| Feasibility Studies | 1 | 2007 | 3467 | 0.04 | Why? |
| Electrophysiologic Techniques, Cardiac | 1 | 2021 | 396 | 0.04 | Why? |
| Vitamin B Complex | 1 | 2017 | 49 | 0.04 | Why? |
| Automation | 1 | 2019 | 429 | 0.04 | Why? |
| Valsartan | 1 | 2018 | 206 | 0.04 | Why? |
| Age Factors | 4 | 2018 | 21039 | 0.04 | Why? |
| Algorithms | 3 | 2018 | 7346 | 0.04 | Why? |
| Drug Resistance | 1 | 2019 | 395 | 0.04 | Why? |
| Tachycardia, Ventricular | 1 | 2019 | 251 | 0.04 | Why? |
| Bone Diseases | 1 | 2017 | 101 | 0.04 | Why? |
| Biological Availability | 1 | 2017 | 388 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Capillaries | 1 | 2018 | 257 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.04 | Why? |
| Hypolipidemic Agents | 1 | 2018 | 208 | 0.04 | Why? |
| Stakeholder Participation | 1 | 2019 | 481 | 0.04 | Why? |
| Home Care Services | 1 | 2007 | 1351 | 0.04 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.04 | Why? |
| Syncope | 1 | 2018 | 238 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.04 | Why? |
| Echocardiography, Doppler | 1 | 2017 | 269 | 0.04 | Why? |
| Kidney Diseases | 1 | 2006 | 1434 | 0.04 | Why? |
| Death | 1 | 2018 | 334 | 0.04 | Why? |
| Emigration and Immigration | 1 | 2020 | 501 | 0.04 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.03 | Why? |
| Pulmonary Circulation | 1 | 2016 | 207 | 0.03 | Why? |
| Child, Preschool | 4 | 2019 | 36283 | 0.03 | Why? |
| International Cooperation | 2 | 2018 | 3436 | 0.03 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2019 | 584 | 0.03 | Why? |
| Patient Admission | 2 | 2021 | 5250 | 0.03 | Why? |
| Positive-Pressure Respiration | 1 | 2002 | 1160 | 0.03 | Why? |
| Peru | 1 | 2018 | 1010 | 0.03 | Why? |
| Acute Disease | 1 | 2006 | 6029 | 0.03 | Why? |
| Office Visits | 1 | 2018 | 489 | 0.03 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.03 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.03 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.03 | Why? |
| Overweight | 1 | 2019 | 916 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.03 | Why? |
| Socioeconomic Factors | 2 | 2021 | 8495 | 0.03 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 520 | 0.03 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2019 | 1755 | 0.03 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.03 | Why? |
| Metabolic Syndrome | 1 | 2019 | 810 | 0.03 | Why? |
| Research Design | 2 | 2018 | 5830 | 0.03 | Why? |
| Health Care Surveys | 1 | 2021 | 2942 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2018 | 1215 | 0.03 | Why? |
| Atherosclerosis | 1 | 2019 | 768 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Poland | 1 | 2018 | 2368 | 0.03 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.03 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2017 | 1706 | 0.02 | Why? |
| Cost of Illness | 1 | 2020 | 1903 | 0.02 | Why? |
| Ambulatory Care | 1 | 2007 | 4947 | 0.02 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Heart-Assist Devices | 1 | 2017 | 812 | 0.02 | Why? |
| Precision Medicine | 1 | 2019 | 1477 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Netherlands | 1 | 2017 | 3533 | 0.02 | Why? |
| Epitopes | 1 | 2020 | 4113 | 0.02 | Why? |
| Animals | 2 | 2017 | 78931 | 0.02 | Why? |
| Smoking | 1 | 2021 | 3358 | 0.02 | Why? |
| Vitamin D Deficiency | 1 | 2021 | 1782 | 0.02 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.02 | Why? |
| Disease-Free Survival | 1 | 2012 | 1654 | 0.02 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.02 | Why? |
| Health Resources | 1 | 2020 | 2592 | 0.02 | Why? |
| Endothelium, Vascular | 1 | 2018 | 1751 | 0.02 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Software | 1 | 2018 | 2501 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Quality Improvement | 1 | 2019 | 2435 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2018 | 3444 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Immunity | 1 | 2017 | 2651 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2018 | 2844 | 0.02 | Why? |
| Research | 1 | 2018 | 2115 | 0.02 | Why? |
| Periodicals as Topic | 1 | 2018 | 1492 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.02 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.02 | Why? |
| Tilt-Table Test | 1 | 2003 | 20 | 0.02 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.02 | Why? |
| Pediatrics | 1 | 2019 | 2969 | 0.02 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.02 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.02 | Why? |
| Healthcare Disparities | 1 | 2021 | 3893 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Tachycardia | 1 | 2003 | 239 | 0.01 | Why? |
| China | 2 | 2020 | 50654 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.01 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.01 | Why? |
| Nervous System Diseases | 1 | 2017 | 4092 | 0.01 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.01 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.01 | Why? |
| Wakefulness | 1 | 2002 | 598 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Multivariate Analysis | 1 | 2003 | 5440 | 0.01 | Why? |
| Pregnancy | 1 | 2014 | 23879 | 0.01 | Why? |